Why the study?
Severe COVID-19 progressions are triggered by excessively high cytokine levels, leading to the hypothesis that impairment of the vagally driven cholinergic anti-inflammatory pathway critically determines disease severity.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
May support vagal stimulation for cytokine storm in COVID-19; leaves open need for randomized trials.
COVID-19 has left mankind desperately seeking how to manage dramatically rising infection rates associated with severe disease progressions. COVID-19 courses range from mild symptoms up to multiple organ failure and death, triggered by excessively high serum cytokine levels (IL 1β, IL 6, TNF α, IL 8). The vagally driven cholinergic anti-inflammatory pathway (CAP) stops the action of nuclear factor κB (NF-κB), the transcriptional factor of pro-inflammatory cytokines. Thus, well-balanced cytokine release depends on adequate vagal signaling. Coronaviruses replicate using NF-κB transcriptional factor as well. By degrading the cytoplasmatic inhibitor of NF-κB subunits (IκB), coronaviruses induce unrestricted NF-κB expression accelerating both, virus replication and cytokine transcription.We hypothesize that CAP detriment due to depressed vagal tone critically determines the severity of COVID-19.
No takes yet. Share an insight, caveat, or question.
Leitzke et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: